featured
Concomitant Use of Selective Serotonin Reuptake Inhibitors With OACs and Risk of Major Bleeding
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Concomitant Use of Selective Serotonin Reuptake Inhibitors With Oral Anticoagulants and Risk of Major Bleeding
JAMA Netw Open 2024 Mar 04;7(3)e243208, AA Rahman, RW Platt, S Beradid, JF Boivin, S Rej, C RenouxFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.